X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (487733) 487733
Newsletter (12243) 12243
Book Chapter (1343) 1343
Newspaper Article (1109) 1109
Magazine Article (750) 750
Book / eBook (516) 516
Dissertation (367) 367
Conference Proceeding (182) 182
Publication (150) 150
Web Resource (102) 102
Journal / eJournal (67) 67
Government Document (33) 33
Trade Publication Article (31) 31
Reference (26) 26
Book Review (25) 25
Streaming Video (14) 14
Transcript (8) 8
Paper (5) 5
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (364804) 364804
female (218214) 218214
male (181424) 181424
oncology (175293) 175293
middle aged (173102) 173102
cancer (149711) 149711
aged (148950) 148950
adult (118879) 118879
carcinoma (115390) 115390
prognosis (77560) 77560
surgery (67080) 67080
chemotherapy (64027) 64027
animals (61412) 61412
aged, 80 and over (58765) 58765
tumors (58459) 58459
treatment outcome (54659) 54659
metastasis (54193) 54193
care and treatment (54168) 54168
neoplasm staging (50393) 50393
research (49485) 49485
survival (48335) 48335
retrospective studies (48220) 48220
expression (46494) 46494
radiotherapy (45873) 45873
analysis (40872) 40872
therapy (40167) 40167
cell line, tumor (39921) 39921
mice (38834) 38834
apoptosis (37672) 37672
squamous cell carcinoma (34276) 34276
health aspects (33789) 33789
medicine & public health (32609) 32609
combined modality therapy (31917) 31917
follow-up studies (31295) 31295
survival rate (30392) 30392
antineoplastic combined chemotherapy protocols - therapeutic use (30240) 30240
radiology, nuclear medicine & medical imaging (29676) 29676
risk factors (29635) 29635
hepatocellular carcinoma (29193) 29193
immunohistochemistry (28999) 28999
breast cancer (28590) 28590
patients (27403) 27403
lung neoplasms - drug therapy (26761) 26761
diagnosis (26686) 26686
antineoplastic agents - therapeutic use (26055) 26055
gene expression (25772) 25772
survival analysis (25509) 25509
carcinoma, squamous cell - pathology (25480) 25480
pathology (24800) 24800
gastroenterology & hepatology (24596) 24596
lung neoplasms - pathology (24595) 24595
proteins (24231) 24231
squamous-cell carcinoma (23759) 23759
lung cancer (23664) 23664
cancer therapies (23536) 23536
hepatocellular-carcinoma (22882) 22882
genetic aspects (22647) 22647
medical prognosis (22200) 22200
disease-free survival (22115) 22115
development and progression (21699) 21699
cell biology (21670) 21670
metastases (20963) 20963
time factors (20600) 20600
adenocarcinoma (20309) 20309
liver cancer (19679) 19679
carcinoma, non-small-cell lung - drug therapy (19186) 19186
medicine (18978) 18978
lymphatic metastasis (18834) 18834
breast neoplasms - pathology (18759) 18759
medicine, research & experimental (18251) 18251
hematology, oncology and palliative medicine (18202) 18202
management (18110) 18110
mutation (17792) 17792
cisplatin (17610) 17610
breast-cancer (17502) 17502
gene expression regulation, neoplastic (17125) 17125
pharmacology & pharmacy (17117) 17117
urology & nephrology (16742) 16742
radiation-therapy (16469) 16469
colorectal cancer (16308) 16308
studies (16305) 16305
liver neoplasms - pathology (16301) 16301
oncology, experimental (16253) 16253
biochemistry & molecular biology (16236) 16236
cell proliferation (16204) 16204
growth (16142) 16142
carcinoma, non-small-cell lung - pathology (16125) 16125
research article (15974) 15974
recurrence (15892) 15892
prospective studies (15831) 15831
medical research (15768) 15768
neoplasm invasiveness (15446) 15446
neoplasm metastasis (15320) 15320
risk (15272) 15272
adolescent (15165) 15165
antineoplastic agents - pharmacology (15067) 15067
immunotherapy (14879) 14879
biopsy (14800) 14800
radiation therapy (14772) 14772
kinases (14536) 14536
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (204) 204
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (75) 75
Online Resources - Online (60) 60
Collection Dvlpm't (Acquisitions) - Vendor file (46) 46
Collection Dvlpm't (Acquisitions) - Closed Orders (13) 13
Gerstein Science - Periodical Stacks (13) 13
St. Michael's Hospital - Stacks (11) 11
UofT at Mississauga - Stacks (11) 11
Gerstein Science - Bindery (7) 7
Humber River Regional Hospital - Finch Stacks (5) 5
Lakeridge Health Sciences - Oshawa (5) 5
Robarts - Stacks (5) 5
Credit Valley Hospital - Stacks (4) 4
Humber River Regional Hospital - Church Stacks (4) 4
Markham Stouffville Hospital - Stacks (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Periodicals (4) 4
Baycrest Hospital - Wellness Library (3) 3
Gerstein Science - Circulation Desk (3) 3
Scarborough Hospital - Birchmount (3) 3
Scarborough Hospital - General (3) 3
University College (Laidlaw) - Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Women's College Hospital - Stacks (3) 3
Credit Valley Hospital - Special Collections (2) 2
Gerstein Science - Reference (2) 2
Lakeridge Health Sciences - Online (2) 2
New College (Ivey) - Stacks (2) 2
Providence Healthcare - Stacks (2) 2
Scarborough Hospital - Online (2) 2
St Josephs Health Centre - Stacks (2) 2
Sunnybrook Health Sciences Centre - Online (2) 2
UTL at Downsview - May be requested (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Markham Stouffville Hospital - Storage (1) 1
Mathematical Sciences - Stacks (1) 1
Media Commons - Audio Visual (1) 1
OISE - Stacks (1) 1
Regis College - Circulation Desk (1) 1
Richard Charles Lee Canada-Hong Kong - Library use only (1) 1
Robarts - Gov Pub Storage: Request at Reference Desk 4th floor (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - Audio Visual (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Online (1) 1
Trillium Health Centre - Stacks (1) 1
UofT Schools - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (472764) 472764
German (9649) 9649
Japanese (8800) 8800
French (6621) 6621
Chinese (3871) 3871
Russian (2079) 2079
Spanish (2049) 2049
Italian (1395) 1395
Polish (1135) 1135
Korean (893) 893
Portuguese (430) 430
Czech (382) 382
Hungarian (335) 335
Dutch (285) 285
Turkish (155) 155
Danish (148) 148
Serbian (122) 122
Bulgarian (119) 119
Romanian (102) 102
Croatian (93) 93
Hebrew (75) 75
Norwegian (60) 60
Ukrainian (51) 51
Finnish (42) 42
Swedish (38) 38
Arabic (33) 33
Slovak (32) 32
Persian (21) 21
Lithuanian (20) 20
Icelandic (11) 11
Slovenian (10) 10
Bosnian (8) 8
Greek (5) 5
Latvian (3) 3
Afrikaans (2) 2
Georgian (2) 2
Catalan (1) 1
Manx (1) 1
Thai (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer gene therapy, ISSN 0929-1903, 1994
Journal
Molecular cancer therapeutics, ISSN 1535-7163, 2001
Journal
Seminars in radiation oncology, ISSN 1532-9461, 1991
Journal
Radiography, ISSN 1532-2831, 1995
Journal
Cancer biology & therapy, ISSN 1538-4047, 2002
Journal
Annals of oncology, ISSN 0923-7534, 2015, Volume 26, Issue 8, pp. 1533 - 1546
The 14th St Gallen International Breast Cancer Conference (2015) reviewed substantial new evidence on locoregional and systemic therapies for early breast cancer... 
early breast cancer | systemic adjuvant therapies | St Gallen Consensus | radiation therapy | surgery | Radiation therapy | Early breast cancer | Systemic adjuvant therapies | Surgery | ADJUVANT CHEMOTHERAPY | ENDOCRINE THERAPY | PREMENOPAUSAL WOMEN | ESTROGEN-RECEPTOR | PATHOLOGICAL COMPLETE RESPONSE | TUMOR-INFILTRATING LYMPHOCYTES | OVARIAN-FUNCTION SUPPRESSION | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | SENTINEL NODE | CONTRALATERAL PROPHYLACTIC MASTECTOMY | Carcinoma, Lobular - pathology | Receptors, Estrogen - metabolism | Humans | Carcinoma, Intraductal, Noninfiltrating - metabolism | Mastectomy - methods | Receptor, ErbB-2 - metabolism | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Anthracyclines - administration & dosage | Carcinoma, Lobular - therapy | Carcinoma, Intraductal, Noninfiltrating - therapy | Antineoplastic Agents, Hormonal - therapeutic use | Axilla | Carcinoma, Ductal, Breast - pathology | Female | Carcinoma, Ductal, Breast - metabolism | Mastectomy, Segmental - methods | Trastuzumab - administration & dosage | Carcinoma, Ductal, Breast - therapy | Taxoids - administration & dosage | Carcinoma, Intraductal, Noninfiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Radiotherapy, Adjuvant - methods | Carcinoma, Lobular - metabolism | Platinum Compounds - administration & dosage | Lymph Node Excision - methods | Neoplasm Staging | Practice Guidelines as Topic | Special
Journal Article
Expert review of anticancer therapy, ISSN 1473-7140, 2001
Journal
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
...) durvalumab in combination with radiotherapy (RT) in an expansion cohort of patients included in a phase 1/2 trial at our institution... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the addition of cetuximab to concurrent... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 4, pp. 846 - 853
...) intensity modulated proton therapy (IMPT) for patients with head and neck tumors. Methods and Materials Fifteen consecutive patients with head and neck cancer underwent MFO-IMPT with active scanning beam proton therapy... 
Radiology | Hematology, Oncology and Palliative Medicine | PHOTON | RADIOTHERAPY | ONCOLOGY | CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | Uncertainty | Follow-Up Studies | Humans | Middle Aged | Proton Therapy - adverse effects | Male | Carcinoma, Squamous Cell - radiotherapy | Chemoradiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Tongue Neoplasms - drug therapy | Nasopharyngeal Neoplasms - radiotherapy | Adult | Female | Radiotherapy Setup Errors | Nasopharyngeal Neoplasms - drug therapy | Radiotherapy Planning, Computer-Assisted | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Carcinoma, Adenoid Cystic - drug therapy | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Stomatitis - etiology | Quality Assurance, Health Care | Head and Neck Neoplasms - radiotherapy | Pilot Projects | Carcinoma, Squamous Cell - drug therapy | Aged | Carcinoma, Adenoid Cystic - radiotherapy | Proton Therapy - methods | Xerostomia - etiology | Head and neck tumors | Sects | Care and treatment | Nuclear radiation | Index Medicus | HEAD | MEV RANGE 10-100 | PATIENTS | CLINICAL TRIALS | PROTON BEAMS | SKULL | TOXICITY | MEV RANGE 100-1000 | PLANNING | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | OPTIMIZATION | NECK
Journal Article
Integrative cancer therapies, ISSN 1552-695X, 2002
Journal
Journal Article
BMC cancer, ISSN 1471-2407, 2019, Volume 19, Issue 1, pp. 901 - 901
Journal Article